Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 17Biopsy 9Magnetic Resonance Spectroscopy 8X-Rays 5Cyclophosphamide 5venetoclax 4fludarabine 4dexamethasone acetate 4dexamethasone 21-phosphate 4auricularum 4Dexamethasone 4Calcium Dobesilate 4carfilzomib 3Hyaluronoglucosaminidase 3sargramostim 2pomalidomide 2decitabine and cedazuridine drug combination 2daratumumab 2balstilimab 2Whole-Body Irradiation 2Stem Cell Transplantation 2Photons 2Melphalan 2Fluorodeoxyglucose F18 2Doxorubicin 2Cytarabine 2Colony-Stimulating Factors 2Busulfan 2trastuzumab deruxtecan 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NIH × Liposomes × Clear all
NCT05554419 2026-04-13

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
184 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡